LGD-2226 (LGD2226) is a selective androgen receptor modulator (SARM) that has been developed as a potential treatment for osteoporosis and other conditions related to muscle wasting. It is known for its ability to promote lean muscle mass growth and improve bone density.
Chemical Name:
The chemical name for LGD-2226 (LGD2226) is N-(4-cyano-3-trifluoromethylphenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide.
Molecular Formula:
C21H16F3N3O3
Formula Weight:
427.36 g/mol
CAS No:
328947-93-9
Top Ten Keywords from Google and Synonyms:
Synonyms: N-(4-Cyano-3-trifluoromethylphenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropionamide, LGD-2226, LGD2226
Health Benefits of LGD-2226 (LGD2226):
LGD-2226 (LGD2226) has been primarily studied for its potential use in treating osteoporosis and other conditions related to muscle wasting. It has also shown promising results in promoting lean muscle mass growth and reducing body fat.
Potential Effects:
LGD-2226 (LGD2226) works by selectively binding to androgen receptors in the body, leading to increased protein synthesis and nitrogen retention. This leads to increased muscle mass and strength, as well as improved bone density.
Product Mechanism:
LGD-2226 (LGD2226) is a selective androgen receptor modulator (SARM) that selectively binds to androgen receptors in the body. This leads to increased protein synthesis and nitrogen retention, which promotes lean muscle mass growth and improves bone density.
Safety:
LGD-2226 (LGD2226) has not yet been approved by the FDA for any medical use and there is limited information available on its long-term safety profile. It should only be used under the supervision of a healthcare provider who can monitor its effects and adjust the dosage as needed.
Side Effects:
Common side effects of LGD-2226 (LGD2226) may include acne, hair loss, mood swings, and decreased libido. More serious side effects are not yet known.
Dosing Information:
The recommended dose of LGD-2226 (LGD2226) for adults is approximately 0.1-1mg/kg/day. It is typically taken orally once per day with or without food.
Conclusion:
LGD-2226 (LGD2226) is a promising selective androgen receptor modulator (SARM) that has shown potential in treating osteoporosis and other conditions related to muscle wasting. It is also known for its ability to promote lean muscle mass growth and improve bone density. However, more research is needed to fully understand its safety profile and potential long-term effects. If you are considering using LGD-2226 (LGD2226), talk to your healthcare provider about the potential risks and benefits.
